BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 3541418)

  • 1. [Avoidance of tolerance development to long term therapy with nitrates through correct dosage].
    Blasini R; Reiniger G; Rudolph W
    Z Kardiol; 1986; 75 Suppl 3():42-9. PubMed ID: 3541418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration].
    Reiniger G; Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance?
    Kośmicki M; Sadowski Z; Szwed H; Kowalik I
    Med Sci Monit; 2000; 6(4):763-8. PubMed ID: 11208406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
    Blasini R; Brügmann U; Reiniger G; Rudolph W
    Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance development during isosorbide dinitrate treatment: can it be circumvented?
    Rudolph W; Blasini R; Reiniger G; Brügmann U
    Z Kardiol; 1983; 72 Suppl 3():195-8. PubMed ID: 6421009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short and long-acting oral nitrates for stable angina pectoris.
    Thadani U; Lipicky RJ
    Cardiovasc Drugs Ther; 1994 Aug; 8(4):611-23. PubMed ID: 7848896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrate therapy in patients with coronary artery disease--preparations and doses with and without development of tolerance.
    Rudolph W; Dirschinger J; Kraus F; Reiniger G; Hall D
    Z Kardiol; 1990; 79 Suppl 3():57-65. PubMed ID: 2099042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
    Kośmicki M; Sadowski Z
    Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness?
    Rudolph W; Dirschinger J; Reiniger G; Beyerle A; Hall D
    Eur Heart J; 1988 Jan; 9 Suppl A():63-72. PubMed ID: 3137072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrate therapy without loss of action by correct dosage.
    Boertz A; Bonn R
    Z Kardiol; 1986; 75 Suppl 3():57-60. PubMed ID: 3798996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrates for angina pectoris. A critical review of therapeutic efficacy and tolerance.
    Thadani U
    Herz; 1984 Jun; 9(3):123-36. PubMed ID: 6430766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dose-response relationship of nitrate therapy of angina pectoris].
    Schneider W; Kaltenbach M
    Z Kardiol; 1986; 75 Suppl 3():61-7. PubMed ID: 3099486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlled clinical studies of tolerance development and dosing problems in nitrate therapy].
    Abshagen U
    Herz; 1996 Jun; 21 Suppl 1():23-30. PubMed ID: 8767921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.
    Silber S
    Eur J Clin Pharmacol; 1990; 38 Suppl 1():S35-51. PubMed ID: 2113003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antianginal efficacy of long-term nitrate therapy.
    Kenedi P; Giebeler B
    Z Kardiol; 1983; 72 Suppl 3():233-8. PubMed ID: 6666227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open, long-term, multi-centre study of the anti-anginal efficacy and safety of isosorbide 5-mononitrate at low doses in patients with coronary heart disease.
    Uberbacher HJ; Steinorth G; Glocke M; Abshagen U
    Pharmatherapeutica; 1983; 3(5):331-41. PubMed ID: 6342004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
    Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
    Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatment and tolerance with high doses of isosorbide dinitrate in a slow release form in patients with angina pectoris.
    Becker HJ; Fach WA; Weil J; Hüwer HD
    Z Kardiol; 1983; 72 Suppl 3():199-202. PubMed ID: 6666222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.